Hepatitis C
Showing NaN - NaN of 61
Cirrhosis, End Stage Liver Disease, Acute Kidney Injury Trial in San Francisco, Aurora, Houston (Esophageal cooling/warming
Recruiting
- Cirrhosis
- +9 more
- Esophageal cooling/warming device
- +2 more
-
San Francisco, California
- +2 more
Jan 20, 2023
HCV-TARGET- Hepatitis C Therapeutic Registry and Research
Active, not recruiting
- Hepatitis C
-
Phoenix, Arizona
- +59 more
Oct 5, 2022
HIV, Hepatitis C Trial in Puerto Rico, United States (Pegylated-Interferon Alfa 2b (PEG-IFN), Ribavirin (RBV), Boceprevir (BOC))
Completed
- HIV Infections
- Hepatitis C
- Pegylated-Interferon Alfa 2b (PEG-IFN)
- +2 more
-
Birmingham, Alabama
- +42 more
Nov 2, 2021
Hepatitis C Trial in Puerto Rico, United States (ITX 5061, Placebo ITX 5061)
Completed
- Hepatitis C
- ITX 5061
- Placebo ITX 5061
-
Birmingham, Alabama
- +9 more
Oct 28, 2021
Direct Acting Antiviral-Post Authorization Safety Study
Completed
- Hepatitis C
- Hepatocellular Carcinoma
-
Phoenix, Arizona
- +61 more
Jul 1, 2021
Hepatitis C, Transplantation Disease Transmission Trial in United States (Sofosbuvir/Velpatasvir,
Completed
- Hepatitis C
- Transplantation Disease Transmission
-
San Francisco, California
- +5 more
Feb 10, 2021
Hepatitis B, Hepatitis C, Liver Disease Trial in San Francisco (Video Doctor, PA + PPN)
Completed
- Hepatitis B
- +2 more
- Video Doctor, PA + PPN
-
San Francisco, California
- +1 more
Jul 17, 2020
Hepatitis C, Alcohol Abuse Trial in Palo Alto, San Francisco (Web-Based Brief Alcohol Intervention, Usual Care)
Completed
- Hepatitis C
- Alcohol Abuse
- Web-Based Brief Alcohol Intervention
- Usual Care
-
Palo Alto, California
- +1 more
May 26, 2020
Hepatitis C, Human Immunodeficiency Virus, HIV Trial in San Francisco (Pegylated interferon alfa-2a + Ribavirin)
Completed
- Hepatitis C
- +2 more
- Pegylated interferon alfa-2a + Ribavirin
-
San Francisco, CaliforniaSan Francisco General Hospital/UCSF
May 14, 2020
Hepatitis C, HCV Trial in United States (Glecaprevir/Pibrentasvir (G/P) 300mg/120mg, Ribavirin 200Mg Tablet)
Completed
- Hepatitis C
- HCV
- Glecaprevir/Pibrentasvir (G/P) 300mg/120mg
- Ribavirin 200Mg Tablet
-
Palo Alto, California
- +30 more
Feb 17, 2020
Subjects Who Participated inPrevious Asunaprevir and/or
Completed
- Hepatitis C
- Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052)
-
Montgomery, Alabama
- +160 more
Nov 26, 2019
Adult-to-Adult Living Donor Transplant Cohort Study
Completed
- Liver Diseases
- +4 more
-
San Francisco, California
- +8 more
Feb 7, 2019
Hepatitis C, Hepatitis C, Chronic, Nonimmune Nonviral Causes of Liver Failure Trial in United States (drug, procedure, other)
Completed
- Hepatitis C
- +2 more
- calcineurin inhibitor-based immunosuppression
- +3 more
-
San Francisco, California
- +7 more
Jan 15, 2019
HIV-1 Infection, Hepatitis C Trial in San Francisco, New York (Ledipasvir/sofosbuvir, Ribavirin)
Terminated
- HIV-1 Infection
- Hepatitis C
-
San Francisco, California
- +1 more
Apr 2, 2018
Hepatitis C (HCV) Cure and Kidney Health
Unknown status
- Hepatitis C
- Elbasvir / Grazoprevir Oral Tablet [Zepatier]
-
San Francisco, California
- +1 more
Apr 16, 2018
Adult-to-Adult Living Donor Liver Transplantation Study
Completed
- Cirrhosis
- +2 more
-
Los Angeles, California
- +8 more
Aug 27, 2017